Iambic Therapeutics Earnings
NASDAQ: IAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
13.11-1.15 (-8.06%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Iambic Therapeutics earnings summary
In its most recent report on Nov 16, 2026 (Sep/2026), IAM posted EPS of $-6.23 versus the $-0.33 consensus estimate, a negative surprise of 1787.9%.
Summary generated from market data by MetaCap's automated system. Methodology
IAM earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 16, 2026 | $-0.33 | $-6.23 | -1787.9% | — |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.